Navigation Links
iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
Date:7/7/2009

iscovery and development. We are now furthering those efforts by bringing together the leading scientists in the field as active colleagues and members of the SAB to create a new and powerful force in the field of stem cell science," said CEO John Walker. "Drs. Daley, Melton and Rubin share our conviction that this effort represents a paradigm shift in the way drug discovery and development will be conducted in the future and maintain a clear focus on the development of new therapeutics."

"Disease-specific pluripotent stem cells are powerful new tools for drug screening and promise to revolutionize the treatment of intractable conditions," said Dr. George Daley. "We are excited to join forces with the iZumi team, and view this as an opportunity to translate our stem cell research efforts into therapeutic realities for patients. Our initial focus will be in neurodegenerative disease and longer term into metabolic and cardiovascular diseases, as well as other therapeutic areas."

iPierian has secured a $10 million investment from MPM Capital, which will augment the original $20 million investment by Kleiner Perkins Caufield & Byers and Highland Capital Partners. "As the founding investor in Pierian, we are delighted to now support the formation of iPierian and a technology that we believe will change the value proposition of drug development," said Dr. Ashley Dombkowski, the managing director at MPM Capital who co-founded Pierian along with MPM managing director Robert Millman. Dr. Dombkowski will join the iPierian Board of Directors and will serve along with current iZumi members, Dr. Corey Goodman, John Walker, Dr. Beth Seidenberg of Kleiner Perkins Caufield & Byers, and Bob Higgins of Highland Capital Partners.

In addition to the investment by MPM, FinTech Capital Partners has invested an additional $1.5 million in this round of financing.

iPierian will continue the collaborations
'/>"/>

SOURCE iZumi Bio, Inc.; Pierian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease
2. iZumi Bio, Inc. Recruits Leading iPS Scientist, John Dimos, to Translate Stem Cell Breakthrough Into Patient Benefits
3. iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer
4. iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development
5. iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. ev3 and FoxHollow Announce Date for Special Meeting of FoxHollow Stockholders to Vote on Proposed Merger
10. IsoTis - Integra Merger
11. New Brunswick Scientific Completes Merger Transaction with Eppendorf
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Bed bugs compromised Penn State. ... confirmed it. Meanwhile, My Cleaning Products offered complimentary samples of ... the pests without using harmful chemical elements. , Based ... the affected building was actually a dormitory , My ... made on May 13 and bed bug presence was confirmed ...
(Date:5/23/2013)... NH (PRWEB) May 23, 2013 Ralph Huber, ... of their emergency management products and emergency survival kits ... , This announcement was made at the quarterly executive board ... with a moment of silence for the Oklahoma tornado victims ... that the quality of their emergency kits is paramount. ...
(Date:5/22/2013)... Mechanicsburg, PA (PRWEB) May 22, 2013 ... Controller with the integrated potentiometers or via a ... compact design measuring two and one half inches square ... from a zero voltage switched, low noise solid state ... line power isolation for the communication port and sensor ...
(Date:5/22/2013)... 2013 iLuv Creative Technology, the premier ... the mobile lifestyle, announces they are now shipping MultiCharger-X, ... multiple iPad devices efficiently. Winner of the 2013 internationally ... Design award, MultiCharger-X is revolutionizing the way businesses, schools, ... deployed. , MultiCharger-X (iAD910) combines the ...
Breaking Biology Technology:Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2PHI Emergency Management on Announces Father's Day Specials All Emergency Survival Kits 2New AC Temperature Controller Announced by Oven Industries 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3
... Fincor (Pink Sheets: FINC) through a share ... leading company in the field of water technologies, enlarges its ... Fincor also acquired the WETTECH and Advanced Cavitation Technologies. ... several natural drugs to fight Malaria and Dengue fever and ...
... Tigris Pharmaceuticals, Inc., a privately held drug development ... Phase I clinical trial of GGTI-2418. GGTI-2418 is ... that induces apoptosis by downregulating several pivotal oncogenic and ... Dr. Peter O,Dwyer, Professor of Medicine at the ...
... and Student Research, Partnering with Industry , ... ... University of Massachusetts Boston today officially opened a cutting-edge ... university,s research and development activity and provide entrepreneurial opportunities for ...
Cached Biology Technology:Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 3UMass Boston Opens Venture Development Center to Expand R&D Activity 2UMass Boston Opens Venture Development Center to Expand R&D Activity 3UMass Boston Opens Venture Development Center to Expand R&D Activity 4
(Date:5/22/2013)... together in a major new effort to educate the ... Earth,s people with clean water that looms ahead in ... article in the current edition of Chemical & ... Chemical Society (ACS), the world,s largest scientific society. , ... Jerald L. Schnoor, Ph.D., explain that shortages of reliable ...
(Date:5/22/2013)... responsible for legionellosis, an infectious disease that can lead ... has developed a complex method enabling it to camouflage ... these acting against the infectious bacteria. , Research led ... which teams from the National Institute of Health (NIH) ... Barcelona (BSC) have also participated, has described for the ...
(Date:5/21/2013)... long time that some creatures evolve more quickly than ... But it may be that height plays a role, ... U. S. National Evolutionary Synthesis Center. , In ... journal Nature Communications , Lanfear and colleagues report ... a database of global patterns in plant height for ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Small but speedy: Short plants live in the evolutionary fast lane 2
... has waged a successful guerrilla war against the human immune ... Journal of Biological Chemistry has exposed one of the ... may aid in future drug development. , Malaria parasites (plasmodia) ... human hosts the parasites first set up shop in liver ...
... the world,s plant species rely on animals to transfer their ... pollinators is the bee, made up of about 30,000 species ... than half of the world,s flowering plants. In recent years, ... the U.S. and Europe has placed the health of ecosystems ...
... last decade, childhood obesity has grown into an epidemic, ... recommendations that pediatricians check toddlers for elevated cholesterol. ... intervene. A study presented at a pediatric research ... as early as age two, when children reach a ...
Cached Biology News:Research exposes new target for malaria drugs 2Saving our bees 2Saving our bees 32 years old -- a childhood obesity tipping point? 2
... Antigen Afinity Purified Tyrosine Hydroxylase ... antibody was raised against synthetic ... residues surrounding the phospho-Ser40 of ... antibody was purified by sequential ...
Monoclonal Antibody to GLP Immunogen: Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3)...
Biotin anti-human CD164...
Co-precipitant is free of background polynucleotides,Dnases,Rnases, proteases. 20mg/ml...
Biology Products: